P132-0593 Screening compound: N-(cyclohexylmethyl)-4-[3-(piperidin-1-yl)pyrazin-2-yl]benzamide

P132-0593 Screening compound: N-(cyclohexylmethyl)-4-[3-(piperidin-1-yl)pyrazin-2-yl]benzamide
P132-0593 Screening compound: N-(cyclohexylmethyl)-4-[3-(piperidin-1-yl)pyrazin-2-yl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P132-0593
N-(cyclohexylmethyl)-4-[3-(piperidin-1-yl)pyrazin-2-yl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P132-0593

Molecular Formula

C23H30N4O (C23 H30 N4 O)

Compound Name

N-(cyclohexylmethyl)-4-[3-(piperidin-1-yl)pyrazin-2-yl]benzamide

IUPAC name

N-(cyclohexylmethyl)-4-[3-(piperidin-1-yl)pyrazin-2-yl]benzamide

SMILES

O=C(c(cc1)ccc1-c1nccnc1N1CCCCC1)NCC1CCCCC1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

378.52

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.455

Distribution Coefficient, logD

4.455

Water Solubility, LogSw

-4.34

Polar Surface Area

46.824

Acid Dissociation Constant (pKa)

13.37

Base Dissociation Constant (pKb)

2.89

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.20

P132-0593 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Cardiovascular Library (22201 compounds)

GPCR Targeted Library (31838 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cardiovascular
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P132-0593 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P132-0593?
Check Price and Availability of P132-0593, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P132-0593 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P132-0593
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P132-0593
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P132-0593 available by request